Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Alteration in serotonin 5HT2A receptors and dopamine D2-like receptors in human Alzheimer’s disease brains

Archana Venugopal and Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1853;
Archana Venugopal
1Radiological Sciences, University of California, Irvine, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jogeshwar Mukherjee
1Radiological Sciences, University of California, Irvine, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1853

Objectives Accumulation of senile plaques (SP) and neurofibrillary tangles (NFT) affects neurotransmitter-receptor functions in the Alzheimer’s disease (AD) brain. Previous studies have shown some loss of serotonin and dopamine receptors in AD. We report our results on the evaluation of serotonin 5HT2A and dopamine D2-like receptors in frontal cortex (FC) in post-mortem human AD and control brain in relation to Aβ -amyloid.

Methods Human post-mortem brain samples (AD, n=6, age 75-92, SP Stage C and controls, n=6; age 73-90, SP Stage 0-A) were obtained from UCI ADRC and Banner Health. Brain slices (10 μm thick) of FC and cerebellum (CB) of the frozen tissue were obtained on a Leica 1850 cryotome. Adjacent brain slices were incubated with 3H-spiperone (0.4 μCi/cc), in the presence of sulpiride (100 μM), or ketanserin (10 μM) in 50 mM Tris/pH 7.4 buffer 24 °C for 1 hr. Adjacent sections were tested for Aβ using 3H-PIB (0.03 μCi/cc; 80 Ci/mmol). Using the Optiquant program, regions of interest were drawn to quantify the percentage change in binding of the radiotracers.

Results Presence of Aβ -amyloid plaques in the FC of AD subjects was confirmed using 4G8 immunostains and 3H-PIB. Binding of 3H-spiperone was evident in FC of all subjects while CB exhibited little binding. Gray matter (GM) to white matter (WM) ratios computed for all subjects showed control=3.37 and AD=2.55, showing a 24% decrease in AD. Using ratio of total binding in the absence/presence of ketanserin, control=2.96 and AD=3.49, an 18% increase was measured, while using WM ratios a 26% decrease was observed. In the presence of sulpiride, control=1.61 and AD=1.38, a 15% decrease was seen and using WM a 19% decrease was measured.

Conclusions Our preliminary results are consistent with previous findings which indicate that both serotonin 5HT2Aand dopamine D2-like receptors are affected in AD FC regions that exhibit high Aβ -amyloid as evidenced by 3H-PIB binding. Further analysis and studies on additional subjects are underway in order to evaluate reliability of WM and CB as a reference region.

Research Support NIH/NIA R33AG030524, R01AG029479.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alteration in serotonin 5HT2A receptors and dopamine D2-like receptors in human Alzheimer’s disease brains
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Alteration in serotonin 5HT2A receptors and dopamine D2-like receptors in human Alzheimer’s disease brains
Archana Venugopal, Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1853;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Alteration in serotonin 5HT2A receptors and dopamine D2-like receptors in human Alzheimer’s disease brains
Archana Venugopal, Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1853;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

MTA II: Neurology Posters

  • Correlation of metabolic and volumetric metrics of the structures of the temporal lobe on MRI and FDG-PET in patients with mesial temporal sclerosis
  • Correlations between [18F]FDG-PET and Naa/mI spectroscopy data of the posterior cingulate cortex in amnestic mild cognitive impairment and Alzheimer’s disease.
  • Role of FDG PET in the Evaluation of Cortical Function in Children with Agenesis of Corpus Callosum
Show more MTA II: Neurology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire